Category Archives: Uncategorized

Away Rotation at Tuba City Regional Health Care (TCRHC):

TCRHC is a single-story, 73 bed, Native referral hospital about 90 minutes from Flagstaff, Arizona, and 60 minutes southeast of the Grand Canyon National Park. The health center, provides services to a 6,000 square mile area and serves as a referral center for the western part of the Navajo and Hopi Reservations, and serves the Navajo, Hopi, and Southern Paiute tribes. During your time at TCRHC, you will be exposed to the broadest possible practice scope to provide a glimpse of what their providers do on a daily basis.  Your rotation will include, but not be limited to, experience in the outpatient department, the inpatient service, as well as home visits with community health nurses.  In the outpatient portion, you will be working with not only several providers, but also with many specialists (neurology, cardiology, nephrology, dermatology, and rheumatology).  Your days will be split into half day portions – a morning portion and an afternoon portion.  You will be working with different providers each half day.  When you are on the inpatient service, you will be primary call for the ER and outside facilities wishing to transfer patients to Tuba City.  You will work closely with an inpatient attending to manage patients from admission to discharge.  Upon your arrival at Tuba City, you will discuss your schedule with the rotation director, Dr. Trung Pham.

Residents who have rotated at TCRHC have described it as one of the most unique and rewarding experiences they have had. They have enjoyed being a hospitalist, intensivist, and primary care physician all at the same time while caring for some of the most underserved patients in the United States and developing an understanding of how to provide care in a resource-poor setting. In addition, you’ll have weekends off and are only a short drive away from numerous national parks and opportunities for outdoor recreation. You may have the ability meet visiting residents from other institutions.

​Please note, you need a car for this away elective, so driving to Arizona or flying there and renting a car are both options. There is also a nominal, out of pocket fee for lodging (about 20 dollars per day). This rotation is best if you can go with another resident (to offset travel costs and to have a hiking buddy for the weekends). Rotations are 2-4 weeks in length (preferably 4 weeks).

7/27/16 AM Report: Thyrotoxic periodic paralysis

Epidemiology:

-95 % of cases occur in men, usually young age (~20-39)
-Highest incidence in Asian descent but also seen in those of American Indians and Hispanic descent
-Any etiology of hyperthyroidism can be involved, but most commonly it is Grave’s disease
-Also exists in familial form (familial periodic paralysis)

Pathogenesis

-Thought to be a “channelopathy ” and thyroid hormone increases Na/K ATPase activity in skeletal muscle, driving potassium into the cell.
-High carb meals (more insulin release==>more shift of potassium into cells), ethanol, and over-exertion can trigger attack

Lab/Clinical features

-Proximal muscle weakness, with LE weakness>UE weakness, commonly presents in AM with inability to move lower extremities!
-Varying degrees of hypokalemia
-Mild hypomagnesemia, hypophosphatemia
-Elevated FT4, low TSH
-Elevated CK
-EKG with sinus tachycardia and often U waves (from hypokalemia)

DDX

1)Myasthenia Gravis (more sub-acute/chronic symptoms, more ptosis, bulbar weakness)
2)Botulism (hx of IVDU, black tar heroin, descending paralysis with CN paralysis and eye involvement)
3)GBS (2-4 weeks after GI illness, also ascending paralysis but with paresthesias and bulbar signs

Treatment

1)do NOT over-correct potassium as it can lead to rebound hyperkalemia!
2)Correct with ~10 meQ q1h KCL, check chem 7 q4h and MAX of 90 meQ/24 hour period
3)Treatment of Thyrotoxicosis with MMI and Propranolol (watch for agranulocytosis with MMI!)

7/19/16 AM Report: Cholangitis

Cholangitis=bacterial infection in patient with biliary obstruction and stasis (eg: stones-most common, stenosis, malignancy)- high mortality if not treated!

What is Charcot’s Triad and Reynolds’ Pentad?

Charcot’s Triad: Fever, RUQ, Jaundice, ~50-75 % of patients
Reynold’s Pentad: Fever, RUQ, Jaundice, AND hypotension, AMS

Workup

Abdominal ultrasound/MRCP to evaluate for biliary dilation
Blood cultures
CBC (elevated leukocytosis), LFT (cholestatic pattern of injury)

What is a normal CBD diameter?

~4-6 mm,normal range can slightly increase in later decades of life

Most common etiologies of cholangitis

1)E.coli (25-50 %)
2)Klebsiella (15-20 %)
3)Enterobacter (5-10 %)
4)Enterococcus (10-20 %)
5)Anaerobes (usually mixed)

Treatment

1)Empiric antibiotics choices

a)Beta lactam/Beta Lactamase inhibitor (eg: Zosyn)
b)CTX/Flagyl
c)Cipro/Flagyl
d)Carabapenem

2) ERCP within 24-48 hours for endoscopic sphincterotomy with stone extraction and/or stent insertion- can be both diagnostic and therapeutic!

 

7/14/16 AM Report: Insulinoma

Whipple’s Triad:

  1. Symptoms consistent with hypoglycemia
  2. Documented low plasma glucose when symptoms present
  3. Relief of symptoms following resolution of hypoglycemia

Physiological response to hypoglycemia:

hypo1a

Endogenous Insulin Synthesis:

biosynthesis-of-insulin

  • Endogenous insulin is formed as two insulin chains (A & B) linked by C-peptide.  Measurement of C-peptide can help distinguish from endogenous versus exogenous insulin.

Causes of Hypoglycemia:

  1. Drugs (insulin, sulfonylureas, alcohol)
  2. Critical illness (hepatic failure, sepsis, etc.)
  3. Hormone deficiency (cortisol, glucagon, etc.)
  4. Non-islet cell tumor ~ increased production of IL-GF2 resulting increased glucose utilization
  5. Endogenous insulin
    • Insulinoma
    • Non-insulinoma Pancreatogenous Hypoglycemic Syndrome (NIPHS)
    • Post-gastric bypass hypoglycemia
    • Antibody to insulin / Antibody to insulin receptor

Interpretation of 72 hour glucose fast data:

Capture

*Remember the only way to distinguish between insulinoma, NIPHS, PGBH and a sulfonylurea ingestion is with a urine sulfonylurea toxicity screen!

07/13/16 AM Report-Digoxin toxicity

What is Digoxin and how does it work?

  • Cardiac glycoside extracted from the Foxglove plant (Digitalis Lanata)
  • Blocks the Na+/K+ ATPase in the myocardium

Potential uses of digoxin

  • Atrial fibrillation(lowers heart rate by increasing refractory period
  • Heart failure (due to + Inotropy)

Digoxin toxicity

Check Digoxin level
GI: N/V/anorexia/diarrhea
Visual: blurred vision, yellow/green discoloration (Xanthopsia), haloes
CV: palpitations, syncope, dyspnea
CNS: cofusion/dizziness/fatigue/delirium

Most common EKG findings of Digoxin use 

  • PVC (most common finding)
  • Heart block
  • U Waves
  • Scooped ST-depressions (the Salvador Dali mustache)
  • Combo of SVT with slow ventricular response (eg: atrial tachycardia with block)

*From Rapid Interpretation of EKG’s copyright © 2016 COVER Publishing Co. Inc.

Treatment

  • Discontinue Digoxin!
  • Dig fab fragments (Digibind) if life threatening/HD unstable arrthymia,
  • hyperkalemia (K>5.5), or end-organ damage from hypoperfusion (eg: renal failure/AMS)
  • Remember that HYPOkalemia worsens toxicity (less potassium=more digoxin binding at Na/K ATPase) and digoxin toxicity causes HYPERkalemia (if Na/K+ ATPase not working, cant pump potassium into the cell)

7/12/16 AM Report – Pancreatitis

Remember the common (and not so common) causes of pancreatitis (I GET SMASHED):

Idiopathic

Gallstones
ETOH
Trauma

Steroids
Mumps
Autoimmune
Scorpion stings (species found on the island of Trinidad)
HyperTG/Ca2+
ERCPs
Drugs
* Gallstones and alcohol account for approximately 80% of all cases in the US

Diagnosis of pancreatitis (requires 2 of 3):

  1. Typical clinical symptoms
  2. Elevated Lipase > 3 x the ULN
  3. Imaging findings consistent with pancreatitis

Clinical predictors of worse prognosis:

  • Older age (usually 55-75 years old)
  • Alcohol – increased risk for pancreatic necrosis and need for intubation
  • Obesity (BMI > 30) OR 2.9
  • Multiple medical co-morbidities

Management Principles:

  1. Fluid Replacement
    • 5-10 mL/kg/hr of isotonic crystalloid solution unless contraindicated 
    • Avoid LR in patients with hypercalcemia since it contains calcium
    • Re-evaluate frequently in the first 6 hours and adjust rate as necessary
  2. Pain Management
    • Typically IV opiates in PCA form
    • Dilaudid/fentanyl are good choices; morphine has been shown to increase sphincter of Oddi pressure, but no studies exist to suggest worse outcomes
  3. Nutrition
    • Oral feeds can be resumed in mild pancreatitis as soon as pain controlled/patient hungry
    • Enteral feeds are preferred over parental feeds; place NJ tube beyond ligament of Trietz if possible – but NG preferred to NPO
  4. Antibiotics
    • prophylactic antibiotics are not recommended regardless of the type (interstitial/narcotizing) or severity (mild/moderate/severe)

07/11/16 AM REPORT – STICKY KLEB

Sticky Klebsiella (Hypermucoid variant) 

Diagnosis of Hypermucoid variant Klebsiella (Hypermucoviscosity phenotype) 

String test done in lab after identifying Klebsiella pneumoniae, + test is >5 mm viscous string from the colony on an agar plate

FIG. 1.

(c) Andres Rivero et al. J. Clin. Microbiol. 2010;48:639-641

Risk factors for KLA (Klebsiella Liver Abscess)

DMII (poor neutrophil control impairs neutrophil phagocytosis of capsular subtypes)
Asian descent (especially Taiwan)
Prior antibiotic use

Clinical manifestations

Fever (93 %)
RUQ tenderness (71 %)
N/V/diarrhea
Leukocytosis

Complications (in addition to liver abscess)

Endolphalmitis (ask about ocular symptoms daily!)
Meningitis, Brain Abscess

Treatment

Drainage of liver abscess
Cephalosporins (commonly CTX), can add Flagyl if anaerobic coverage needed, plan for     4-6 weeks antibiotic course depending on resolution of abscess

07/05/16 AM Report – DRESS SYNDROME

DRESS SYNDROME- 07/06/16

Most commonly implicated drugs

1)Anti-seizure medications- Phenytoin, Carbamazepine, Lamotrigine etc.
2)Allopurinol
3)Sulfa drugs

Timing

Usually symptoms start 2-8 weeks after exposure (much later than SJS/TEN)

Systemic Symptoms 

Fever, Malaise, Lymphadenopathy, Morbilliform eruption
Mucosal involvement less common than TEN/SJS
Facial edema in 50 % of cases

Lab abnormalities

Leukocytosis with eosinophilia (usually >700 microL)
Atypical lymphocytosis
Increased LFT, proteinuria, and any organ system can be involved

Treatment

Discontinue the offending drug!
Solumedrol 1 g/kg if organ involvement (evidence is limited)

DRESS syndrome and other drug eruptions

 

7/6/16: SBP versus Secondary Peritonitis

Diagnosis of SBP:

  1. PMNs >250 cells/mm3
  2. Positive bacterial cultures
  3. Absence of secondary causes (i.e. bowel perforation)

Secondary Peritonitis:

  1. PMNs >250 cells/mm3
  2. Positive bacterial cultures (typically poly microbial)
  3. Surgically treatable intra-abdominal source of infection

Remember it is important to distinguish SBP from secondary peritonitis for two main reasons:

  • Mortality of secondary bacterial peritonitis is approximately 100% without surgical intervention
  • Mortality of SBP approaches approximately 80% if patient undergoes an unnecessary exploratory laparotomy

Common pathogens in SBP:

  • E. coli (43%)
  • Strep species (28%)
  • Klebsiella pneumonia (11%)

SAAG – serum ascites albumin gradient (subtract the ascitic albumin from the serum level)

  • If >1.1 g/dL patient has portal hypertension (97% ACCURATE)

Reasons for Albumin Repletion:

  1. Prevention of post-paracentesis circulatory dysfunction (PPCD)
    • >4L give 6-8 g/L for each L removed
  2. Prevention of renal impairment in cirrhotic patients with SBP
    • Give 1.5 g/kg DAY 1
    • Give 1.0 g/kg DAY 3
  3. Diagnosis/treatment of HRS
    • Give 1.0 g/kg on DAYS 1 AND 2 (maximum of 100 g each)
    • If renal function improves, suggestive of pre-renal hypovolemia; if renal function worsens, suggestive of HRS.

6/30/16: Pulmonary Embolism

  • Remember the risk factors for AQUIRED THROMBOPHILIA:
    • Surgery (OR 21.7)
    • Trauma (OR 12.7)
    • Hospital/SNF (OR 8.0)
    • Cancer undergoing chemotherapy (OR 6.6)
    • Others: estrogen therapy, pregnancy, obesity, smoking
  • Approximately 6% of patients with unprovoked VTEs have an undiagnosed cancer at the time of the VTE; approximately 10% will be diagnosed with cancer in the following year.
  • Use the Well’s PE Criteria for those patients whom you suspect a PE; if the score is <6 consider a D-Dimer to guide management

Wells PE

EKG findings in PE:

  • Sinus tachycardia: approximately 44% of patients
  • S1Q3T3 (acute cor pulmonale): not sensitive/specific; found in 20% of patients with PE
  • RV strain patter (TWI R precordial leads V1-V4): representative of elevated PA pressures; found in approximately 34% of patients

Indications for Thrombolytics in PE:

CLEAR INDICATIONS:

  1. Persistent hypotension / shock due to an acute PE

POSSIBLE INDICATION:

  1. Severe / Worsening RV Dysfunction
  2. Cardiopulmonary arrest due to a PE
  3. Extensive clot burden
  4. Free floating RA / ventricular thrombus
  5. Patient foramen ovale

Contraindications to thrombolytics:

  1.  Intracranial neoplasm
  2. Intracranial / spinal surgery or trauma
  3. History of hemorrhagic stroke
  4. Active bleeding
  5. Any stroke within 3 months

Classification of PE and distinction:

Massive: cardiopulmonary shock or hypotension

Submassive: RV dysfunction / elevated cardiac biomarkers

Low Risk: normal echocardiogram / negative cardiac biomarkers